Ep 62 - Medtronic’s Martha Reviews Year One as CEO: Culture, HeartWare and Giving Meaning to Market Share

Om avsnittet

A year ago, Geoff Martha took over as CEO of medtech's large single company. With the sector in lockdown, the company still undertook a massive reorganization and moved to adopt a new "Medtronic Mindset" that would favor the bold. In this interview, Martha reviews Year 1, sharing some positive outcomes and disappointments. Chris Newmarker, executive editor of life sciences, delivers his Newmarkers Newsmakers featuring items from Abbott, Amazon, CVRx, Medtronic, and migraines. Subscribe on all major podcast platforms - Apple, Google, Amazon, Spotify.

Ep 62 - Medtronic’s Martha Reviews Year One as CEO: Culture, HeartWare and Giving Meaning to Market Share

Om avsnittet

Fler avsnitt

Ep 304 - J&J MedTech's Polyphonic Lead Explains Why Surgical Intelligence Is the Next Big Shift in the OR

Ep 303 - Xeltis CEO Schutte on Building a Business Around Tech that Helps the Body Build New Blood Vessels

Ep 302 - Inner Logic CEO Porras explains how autonomous surgery can save us from looming surgeon shortage

Ep 301 - Medtronic’s Grubb on Bringing a Structuralist Perspective to a Growing Structural Heart Portfolio

Ep 300 - How Mobia Medical’s Stroke Recovery Mission Muscled It Past MedTech’s Public Market Malaise

Ep 299 - Surgical Robotics Recap: Steve Bell on SRS, Karl Storz’s Gaudet and Sovato CEO Brian Miller

Ep 298 - Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off?

Ep 297 - J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients

Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

Ep 295 - Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse